EMCC European Monitoring Centre on Change



Geographic Location

Country: Italy
Location of affected unit(s): Bologna, Milan, Alanno (Pescara), Sermoneta (Latina), Pomezia (Roma).


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.20 - Manufacture of pharmaceutical preparations
Number Employed: 1696

Employment Effects

Announcement Date: 06-09-2017
Planned Job Reductions min: 476
Planned Job Reductions max: 476
Type of Restructuring: Internal restructuring
Employment Effect Start: 14-11-2017
Foreseen End Date: 14-03-2018

Additional Information

Pharmaceutical firm Alfasigma announced 476 dismissals across its Italian sites, namely the offices in Bologna and Milan, and the plants in Alanno (Pescara), Sermoneta (Latina), Pomezia (Roma).

With a total employee base of 1,696, the company is one of the largest pharmaceutical firms in Italy. It was established following a fusion between three large firms in August 2017.

The decision of cutting the jobs is attributed to negative market trends and overlap of job functions due to the recent merger.

Redundancies should affect mainly sales representatives and administrative personnel (456) plus 20 managers.

Unions are taking part in the collective dismissal procedure and wish to influence the outcome thereof, deeming the decision of the management not inline with the company’s industrial plan. In the meantime workers are issuing strikes and demonstrations.